Pages that link to "Q43259523"
Jump to navigation
Jump to search
The following pages link to Role of fat hydrolysis in regulating glucagon-like Peptide-1 secretion (Q43259523):
Displaying 50 items.
- Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action (Q24613405) (← links)
- Glucagon-like peptide-1: The missing link in the metabolic clock? (Q26749185) (← links)
- Stimulation of incretin secreting cells (Q26765259) (← links)
- Laparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure? (Q26778002) (← links)
- G-protein-coupled receptors in intestinal chemosensation (Q26828554) (← links)
- Therapy for obesity based on gastrointestinal hormones (Q27006777) (← links)
- Diagnosis and treatment of diabetes mellitus in chronic pancreatitis (Q27013787) (← links)
- Mapping glucose-mediated gut-to-brain signalling pathways in humans (Q33822337) (← links)
- Effects of high-fat diet and the anti-diabetic drug metformin on circulating GLP-1 and the relative number of intestinal L-cells (Q33898060) (← links)
- Effects of Intraduodenal Infusions of L-phenylalanine and L-glutamine on Antropyloroduodenal Motility and Plasma Cholecystokinin in Healthy Men (Q35834493) (← links)
- Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. (Q35871926) (← links)
- The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes (Q36182540) (← links)
- Effect of L-Tryptophan and L-Leucine on Gut Hormone Secretion, Appetite Feelings and Gastric Emptying Rates in Lean and Non-Diabetic Obese Participants: A Randomized, Double-Blind, Parallel-Group Trial (Q36201039) (← links)
- Role of fatty acid transport protein 4 in oleic acid-induced glucagon-like peptide-1 secretion from murine intestinal L cells (Q36312437) (← links)
- Long chain saturated and unsaturated fatty acids exert opposing effects on viability and function of GLP-1-producing cells: Mechanisms of lipotoxicity (Q36375667) (← links)
- Duodenal GLP-1 signaling regulates hepatic glucose production through a PKC-δ-dependent neurocircuitry (Q37745200) (← links)
- Bowels control brain: gut hormones and obesity (Q37768338) (← links)
- Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? (Q37792839) (← links)
- Nutrition and L and K-enteroendocrine cells (Q37814881) (← links)
- Metabolic surgery-principles and current concepts (Q37922651) (← links)
- Nerveless and gutsy: intestinal nutrient sensing from invertebrates to humans (Q37976164) (← links)
- Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells (Q37983846) (← links)
- Gastrointestinal chemosensation: chemosensory cells in the alimentary tract (Q38004925) (← links)
- The gut endocrine system as a coordinator of postprandial nutrient homoeostasis (Q38036016) (← links)
- Digestive physiology of the pig symposium: secretion of gastrointestinal hormones and eating control (Q38073233) (← links)
- Fat sensing and metabolic syndrome (Q38262627) (← links)
- Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents (Q38304318) (← links)
- Chylomicron formation and glucagon-like peptide 1 receptor are involved in activation of the nutritional anti-inflammatory pathway (Q38338040) (← links)
- Gut fat signaling and appetite control with special emphasis on the effect of thylakoids from spinach on eating behavior (Q38558035) (← links)
- Intestinal GLP-1 and satiation: from man to rodents and back (Q38575560) (← links)
- Role of vesicle-associated membrane protein 2 in exocytosis of glucagon-like peptide-1 from the murine intestinal L cell (Q39041700) (← links)
- Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB. (Q39047697) (← links)
- Dietary lipids and sweeteners regulate glucagon-like peptide-2 secretion. (Q39201298) (← links)
- Essential Role for Protein Kinase Cζ in Oleic Acid-Induced Glucagon-Like Peptide-1 Secretion in Vivo in the Rat (Q39591425) (← links)
- Sensing of triacylglycerol in the gut: different mechanisms for fatty acids and 2-monoacylglycerol (Q41499691) (← links)
- Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP-1 secretion from isolated perfused rat small intestine. (Q42141283) (← links)
- Mechanisms Underlying Metformin-Induced Secretion of Glucagon-Like Peptide-1 from the Intestinal L Cell (Q42495476) (← links)
- Amelioration of glycemic control by sleeve gastrectomy and gastric bypass in a lean animal model of type 2 diabetes: restoration of gut hormone profile (Q43499924) (← links)
- Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c) (Q45204627) (← links)
- Chylomicrons stimulate incretin secretion in mouse and human cells (Q46312766) (← links)
- Functional and association analysis of an Amerindian-derived population-specific p.(Thr280Met) variant in RBPJL, a component of the PTF1 complex (Q47231163) (← links)
- Comparing olive oil and C4-dietary oil, a prodrug for the GPR119 agonist, 2-oleoyl glycerol, less energy intake of the latter is needed to stimulate incretin hormone secretion in overweight subjects with type 2 diabetes (Q48043236) (← links)
- Central Modulation of Energy Homeostasis and Cognitive Performance After Bariatric Surgery (Q48103365) (← links)
- Neuroendocrinology of Adipose Tissue and Gut-Brain Axis (Q48103407) (← links)
- Targeting postprandial glycaemia in children with diabetes: Opportunities and challenges (Q48123950) (← links)
- Comparative Effects of Bile Diversion and Duodenal-Jejunal Bypass on Glucose and Lipid Metabolism in Male Diabetic Rats (Q51295574) (← links)
- Cross-linking of sodium caseinate-structured emulsion with transglutaminase alters postprandial metabolic and appetite responses in healthy young individuals (Q58418189) (← links)
- Bile acid sequestrants improve glycemic control in type 2 diabetes: A proposed mechanism implicating glucagon-like peptide 1 release (Q83968813) (← links)
- Long-term inhibition of intestinal lipase by orlistat improves release of gut hormones increasing satiety in obese women (Q87263146) (← links)
- Glucagon-like Peptide-2 and the Regulation of Intestinal Growth and Function (Q89442824) (← links)